What are the types of the Haraldsson papilla classification?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Haraldsson Papilla Classification Types

The Haraldsson classification system categorizes the duodenal papilla (papilla of Vater) into four distinct morphological types based on endoscopic appearance, which has been validated with substantial inter- and intraobserver agreement and directly impacts biliary cannulation difficulty during ERCP. 1

The Four Haraldsson Types

Type 1: Regular Papilla

  • "Classic appearance" with no distinctive features
  • Standard morphology without unusual characteristics
  • Most common type, representing approximately 38.8% of cases 2
  • Associated with moderate cannulation success rates (74.8%) 3

Type 2: Small Papilla

  • Flat appearance with diameter ≤ 3 mm (approximately 9 French)
  • Represents approximately 14.9% of cases 2
  • Highest risk factor for difficult cannulation (OR 6.88) 4
  • Cannulation success rate of 82.8% with needle-knife papillotomy 3

Type 3: Protruding or Pendulous Papilla

  • Papilla standing out, protruding, or bulging into the duodenal lumen
  • May appear hanging down (pendulous) with orifice oriented caudally
  • Represents approximately 29.4% of cases 2
  • Most frequently associated with difficult cannulation (40.6% difficult cannulation rate) 2
  • Strongest independent risk factor for cannulation difficulty (OR 7.74) 4
  • Cannulation success rate of 80.8% with needle-knife papillotomy 3

Type 4: Creased or Ridged Papilla

  • Ductal mucosa extends distally out of the papillary orifice
  • Appears either on a ridge or in a crease
  • Represents approximately 16.9% of cases 2
  • Significant risk factor for difficult cannulation (OR 4.06) 4
  • Cannulation success rate of 66.7% with needle-knife papillotomy 3

Clinical Relevance

The Haraldsson classification is clinically validated and easy to use regardless of endoscopist experience level 1. The classification demonstrates:

  • Substantial interobserver agreement (κ = 0.62,95% CI 0.58-0.65) 1
  • Substantial intraobserver agreement (κ = 0.66,95% CI 0.59-0.72) 1
  • Similar agreement between expert and non-expert endoscopists 1

Impact on ERCP Outcomes

Type 3 papillae present the greatest technical challenge, with the highest rate of difficult cannulation (40.6%) compared to other types 2. When combined with other risk factors such as periampullary diverticulum (PAD) or poor scope operability, pattern recognition scoring can predict when salvage cannulation techniques (pancreatic duct guidewire placement or wire-guided cannulation) should be employed instead of conventional contrast cannulation 4.

Type 1 papillae, despite being the most common and appearing "regular," paradoxically have the highest rate of post-ERCP pancreatitis (15.2%) 2, suggesting that seemingly straightforward anatomy does not guarantee complication-free procedures.

The classification system enables endoscopists to anticipate technical difficulties and select appropriate cannulation strategies preemptively, including consideration of forceps-assisted cannulation or early transition to needle-knife fistulotomy techniques 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.